The short answer
Ginger powder may change average glucose control, but added hypoglycemia with regular human insulin has not been established. A glucose improvement in a diabetes trial does not by itself prove that interaction.
What this answer covers
Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- insulin, regular, human
The powder study measured glucose control
An eight-week trial tested ginger powder capsules and reported lower fasting glucose and HbA1c measures. It did not supply a regular-human-insulin-specific treatment analysis.
The adverse outcome remains uncertain
Lower average glucose can be beneficial when glucose starts high. It is not the same as a documented episode of hypoglycemia. The inspected abstract does not establish a low-glucose event rate with glulisine.
Keep the preparation boundary
The trial used powder. Its dose cannot be treated as a safe threshold with insulin, and the findings do not cover every ginger extract or multi-ingredient diabetes product.
Review monitoring and timing
Discuss the exact powder product with the diabetes team and follow the prescribed glucose-monitoring and low-glucose treatment plan. The trial does not establish a ginger requirement or a protective spacing interval. Do not change insulin yourself.
Evidence and practical considerations
Timing & monitoring
No established supplement requirement or protective spacing interval with regular human insulin; glucose monitoring does not demonstrate a nutrient need.
- Exact scope
- Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
No glipizide-specific regimen or low-glucose adverse-event analysis in inspected abstract. Glucose improvement is not necessarily hypoglycemia. This does not establish an exact regular-human-insulin interaction.
Research assessment: · Open full citations ↗
Side effects & toxicity
Indirect preparation-specific clinical evidence does not establish added hypoglycemia with regular human insulin.
- Exact scope
- Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
No glipizide-specific regimen or low-glucose adverse-event analysis in inspected abstract. Glucose improvement is not necessarily hypoglycemia. This does not establish an exact regular-human-insulin interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact regular-insulin article with route, concentration and clinical endpoint boundaries. | |
| Research summary published |
Article revision: 001f68475f259e0f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.